Latest imported 13F data
โณ
Showing Q3 2025 data
HedgeTrack has imported Q4 2025 data overall, but ADAR1 Capital Management, LLC's latest available filing here is Q3 2025.

ADAR1 Capital Management, LLC

โ€ขCIK: 1940272โ€ขFiling: Q3 2025

**ADAR1 Capital Management, LLC** manages $1.0B across a diversified portfolio of 203 positions. The firm exhibits significant concentration in select names, notably maintaining a substantial position in ABVX at $114.7M. Further top holdings include KROS ($85.3M), PTGX ($65.7M), and PFG ($50.6M), indicating targeted, high-conviction allocations. This structure suggests a disciplined, bottom-up approach focused on deep value or specific sector opportunities.

Total AUM
$946.2M
+ $53.4M in options
QoQ Performance
+60.1%
Positions
187
+ 13 options
Top 10 Concentration
51.0%
Latest Filing
Q3 2025

Top Holdings Allocation

ABVX
KROS
PTGX
ROIV
ABVX11.5%
KROS8.5%
PTGX6.6%
ROIV5.1%
BOXX3.8%
IMVT3.6%
ETNBGBP3.1%
SPY3.0%

๐Ÿ“ˆ Biggest Buys

IMVT
IMMUNOVANT INC
+319.0%
3.6% of portfolio
ROIV
ROIVANT SCIENCES LTD
+72.5%
5.1% of portfolio
ETNBGBP
89BIO INC
+141.2%
3.1% of portfolio
QURECALL
UNIQURE NV
NEW
1.2% of portfolio
LXEO
LEXEO THERAPEUTICS INC
+955.7%
1.0% of portfolio

๐Ÿ“‰ Biggest Sells

ABVX
ABIVAX SA
-56.0%
11.5% of portfolio
PRTA
PROTHENA CORP PLC
-56.5%
1.4% of portfolio
CGON
CG ONCOLOGY INC
-52.4%
1.0% of portfolio
MLYS
MINERALYS THERAPEUTICS INC
-74.1%
0.3% of portfolio
RAPT
RAPT THERAPEUTICS INC
-35.2%
1.3% of portfolio

Sector Breakdown

Other96.6%
ETF3.0%
Healthcare0.3%

๐Ÿšช Exited Positionssold since Q2 2025

SG7
SAGE THERAPEUTICS INC
SOLD
$6.6M
VERA
VERVE THERAPEUTICS INC
SOLD
$5.3M
โ€”
HELIX ACQUISITION CORP II
SOLD
$4.7M
SHY
ISHARES TR
SOLD
$4.4M
ARDX
ARDELYX INC
SOLD
$3.6M
+45 more exited positions

Changes from Q2 2025

NEW49 new positions
โ†‘68 increased
โ†“49 decreased

Historical Filings

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023